Published in Eur J Pharmacol on February 01, 1972
Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA. Br J Pharmacol (1976) 1.95
Dopamine agonists and interaction with other neurotransmitter systems. Naunyn Schmiedebergs Arch Pharmacol (1977) 0.75
Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents. Naunyn Schmiedebergs Arch Pharmacol (1976) 1.25
The action of L-dopa in rats with the raphe nuclei lesions. Pol J Pharmacol Pharm (1975) 1.07
Serotoninergic mechanism of clonidine and apomorphine interaction. Pol J Pharmacol Pharm (1975) 1.07
Influence of apomorphine on brain serotonin turnover rate. Pharmacol Biochem Behav (1976) 1.01
[Pharmacodynamics and pharmacokinetics of memantine]. Arzneimittelforschung (1983) 0.95
Possible involvement of brain serotonin in apomorphine-induced hypothermia. Eur J Pharmacol (1973) 0.95
Antagonistic effect of cyproheptadine on neuroleptic-induced catalepsy. Pharmacol Biochem Behav (1975) 0.94
Dihydropyridine calcium channel antagonists reduce immobility in the mouse behavioral despair test; antidepressants facilitate nifedipine action. Eur J Pharmacol (1987) 0.92
Purification and characterization of fully deuterated enzymes. Biochim Biophys Acta (1969) 0.90
On the role of serotonin in apomorphine-induced locomotor stimulation in rats. Pharmacol Biochem Behav (1974) 0.89
[Proceedings: On the central action of nomifensine (author's transl)]. Arzneimittelforschung (1976) 0.86
Effect of repeated treatment with tianeptine and fluoxetine on the central alpha(1)-adrenergic system. Neuropharmacology (2001) 0.86
The central antiserotonergic action of mianserin. Psychopharmacology (Berl) (1978) 0.85
Some pharmacological properties of N,N-disubstituted dithiocarbamates and their effect on the brain catecholamine levels. Eur J Pharmacol (1970) 0.84
Influence of midbrain raphe lession on some pharmacological and biochemical effects of apomorphine in rats. Psychopharmacologia (1974) 0.83
Apomorphine and central serotonin neurons. Pol J Pharmacol Pharm (1974) 0.83
The influence of neuroleptics on the behavioural effect of 5-hydroxytryptophan. Pol J Pharmacol Pharm (1979) 0.83
Disulfiram and the drug-induced effects on motility. J Pharm Pharmacol (1968) 0.83
Extraction and purification of 1 H, 2 H, and isotope hybrid algal cytochrome, ferredoxin and flavoprotein. Biochim Biophys Acta (1972) 0.82
The effect of amantadine on motor activity and catalepsy in rats. Psychopharmacologia (1972) 0.82
The hypothermic effect of L-dopa in the rat. Life Sci (1973) 0.81
Some central pharmacological effects of the calcium channel antagonist flunarizine. J Neural Transm Gen Sect (1991) 0.81
The influence of the tricyclic antidepressants on the apomorphine induced hypermotility in rats. Pol J Pharmacol Pharm (1974) 0.81
Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neurons in the brain. Eur J Pharmacol (1976) 0.81
Antidepressant drugs given repeatedly increase binding to alpha 1-adrenoceptors in the rat cortex. Eur J Pharmacol (1985) 0.81
The cleavage of vitamin E galactoside in the rat tissue homogenates. Farmaco (2004) 0.80
Fluvoxamine, a new antidepressant drug, fails to show antiserotonin activity. Eur J Pharmacol (1982) 0.80
Central serotoninmimetic action of phenylpiperazines. Pol J Pharmacol Pharm (1981) 0.80
BAY K 8644 enhances immobility in the mouse behavioral despair test, an effect blocked by nifedipine. Eur J Pharmacol (1988) 0.80
Dihydropyridine calcium channel antagonists as antidepressant drugs in mice and rats. Neuropharmacology (1989) 0.80
Repeated administration of antidepressants enhances agonist affinity for mesolimbic D2-receptors. J Pharm Pharmacol (1989) 0.79
Influence of WA-335, a factor which blocks serotonin receptors, on neuroleptic-induced catalepsy. Arch Immunol Ther Exp (Warsz) (1976) 0.79
Chronic treatment with antidepressant drugs: potentiation of apomorphine-induced aggressive behaviour in rats. Neurosci Lett (1979) 0.79
Hypotheses concerning the mechanism of action of antidepressant drugs. Rev Physiol Biochem Pharmacol (1984) 0.79
Inhibition of RNA and protein synthesis in cell culture by actinomycin D. Bull Acad Pol Sci Biol (1965) 0.79
The effect of repeated administration of antidepressant drugs on the responsiveness of rats to catecholamine agonists. J Neural Transm (1979) 0.78
Butyrophenones and brain serotonin metaboism. Pol J Pharmacol Pharm (1976) 0.78
Effect of repeated treatment with tianeptine and fluoxetine on central dopamine D(2) /D(3) receptors. Behav Pharmacol (2002) 0.78
Disulfiram and some effects of amphetamine in mice and rats. J Pharm Pharmacol (1967) 0.78
The action of apomorphine in rats with striatal lesions. Act Nerv Super (Praha) (1973) 0.78
The involvement of cerebellar dopamine D3 receptors in locomotor activity of rats. J Neural Transm (Vienna) (2008) 0.78
Repeated treatment with imipramine potentiates the locomotor effect of apomorphine administered into the hippocampus in rats. Psychopharmacology (Berl) (1985) 0.78
Antidepressant activity of S-adenosyl-L-methionine in mice and rats. J Basic Clin Physiol Pharmacol (1992) 0.78
Central antiserotonin action of fluperlapine. Pol J Pharmacol Pharm (1986) 0.78
Locomotor hypoactivity and motor disturbances--behavioral effects induced by intracerebellar microinjections of dopaminergic DA-D2/D3 receptor agonists. Pol J Pharmacol (2002) 0.77
1-(m-Chlorophenyl)piperazine: a metabolite of trazodone isolated from rat urine. J Pharm Pharmacol (1979) 0.77
Zimelidine and clomipramine: different influence on fenfluramine but not p-chloroamphetamine-induced pharmacological effects. Neurosci Lett (1980) 0.77
FLA 136: selective agonist at central alpha-adrenoreceptors mediating changes in the turnover of noradrenaline. Naunyn Schmiedebergs Arch Pharmacol (1977) 0.77
The role of dopamine D2 receptor in the behavioral effects of imipramine--study with the use of antisense oligonucleotides. J Physiol Pharmacol (2000) 0.77
The effect of L-DOPA on brain catecholamines and motility in rats. Psychopharmacologia (1971) 0.77
Different pharmacokinetic and pharmacological effects following acute and chronic treatment with imipramine. J Neural Transm (1982) 0.77
Some behavioral effects of repeated administration of calcium channel antagonists. Pharmacol Biochem Behav (1990) 0.77
The effect of disulfiram, diethyldithiocarbamate and dimethyldithiocarbamate on serotonin and 5-hydroxyindole-3-acetic acid brain levels in rats. Biochem Pharmacol (1970) 0.77
Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative. Eur J Pharmacol (1974) 0.77
[Effect of memantine on central neurotransmitter systems. Review of the results]. Arzneimittelforschung (1982) 0.77
The effect of theophylline and caffeine on neuroleptic-induced catalepsy. Pol J Pharmacol Pharm (1977) 0.77
Repeated treatment with imipramine or amitriptyline increases the locomotor response of rats to (+)-amphetamine given into the nucleus accumbens. J Pharm Pharmacol (1985) 0.77
[Evaluation of carbohydrate metabolism in women with previous gestational diabetes mellitus]. Ginekol Pol (1994) 0.76
On the anticataleptic action of cyproheptadine. Pharmacol Biochem Behav (1976) 0.76
Reserpine-induced locomotor stimulation in mice chronically treated with typical and atypical antidepressants. Eur J Pharmacol (1983) 0.76
Apomorphine in the rat nucleus accumbens: effects on the synthesis of 5-hydroxytryptamine and noradrenaline, the motor activity and the body temperature. J Neural Transm (1976) 0.76
Repeated treatment with antidepressant drugs induces subsensitivity to the excitatory effect of 5-HT4 receptor activation in the rat hippocampus. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.76
Effect of repeated treatment with mirtazapine on the central alpha1-adrenergic receptors. J Physiol Pharmacol (2002) 0.76
Effect of repeated treatment with milnacipran on the central dopaminergic system. Pol J Pharmacol (2001) 0.76
The effect of repeated treatment with brofaromine, moclobemide and deprenyl on alpha 1-adrenergic and dopaminergic receptors in the rat brain. Neurosci Lett (1990) 0.76
A possible interaction of quipazine with central dopamine structures. J Pharm Pharmacol (1974) 0.76
Repeated treatment with antidepressant drugs potentiates the locomotor response to (+)-amphetamine. J Pharm Pharmacol (1984) 0.76
Repeated treatment with antidepressant drugs increases the behavioural response to apomorphine. J Neural Transm (1984) 0.76
Action of serotoninmimetics in the behavioral despair test in rats. Commun Psychopharmacol (1979) 0.75
Pharmacological profile of milnacipran, a new antidepressant, given acutely. Pol J Pharmacol (1999) 0.75
Central effects following repeated treatment with antidepressant drugs. Pol J Pharmacol Pharm (1984) 0.75
GC-MS Analysis of beta-Carotene Ethenolysis Products and their Synthesis as Potentially Active Vitamin A Analogues. Toxicol Mech Methods (2008) 0.75
The effects of serotonergic and antiserotonergic drugs on the flexor reflex of spinal rat: a proposed model to evaluate the action on the central serotonin receptor. J Neural Transm (1976) 0.75
Influence of dopamine-like compounds on stereotypy and locomotor activity in atropinized rats. Arch Immunol Ther Exp (Warsz) (1975) 0.75
Influence of NBTI on metabolism of brain-HT. Arch Immunol Ther Exp (Warsz) (1975) 0.75
[A rare case of a foreign body in the jaw sinus]. Otolaryngol Pol (1967) 0.75
[Pharmacological properties of the native calamus (Acorus calamus L) 3. Spasmolytic effect of etheric oil]. Acta Pol Pharm (1966) 0.75
Effect of clonidine on the 5-hydroxytryptamine and 5-hydroxyindoleacetic acid brain levels. Biochem Pharmacol (1973) 0.75
The influence of antineoplastic chemotherapy on the glutathione enzymes activity in the blood. Biofactors (2004) 0.75
Changes of the total antioxidative status of blood cells in the progression of stomach and large bowel cancers in patients subjected to primary radical treatment. Biofactors (2004) 0.75
Influence of benzodiazepines on turnover of serotonin in cerebral structures in normal and aggressive rats. Arch Immunol Ther Exp (Warsz) (1975) 0.75
The influence of apomorphine and tricyclic antidepressant drugs on the level of serotonin and its metabolite in rat brain. Biochem Pharmacol (1975) 0.75
Pharmacologic effects of apomorphine in rats with altered level of brain serotonin. Arch Immunol Ther Exp (Warsz) (1975) 0.75
[Effect of lead and cadmium ions on the ATPase activity of the human erythrocyte membrane]. Folia Med Cracov (1987) 0.75
Disulfiram and the effect of catecholamines on neuroleptic-induced catalepsy in mice and rats. J Pharm Pharmacol (1967) 0.75
Monoamine oxidase inhibitors and certain foods. Pol Tyg Lek (1966) 0.75
On the direct influence of apomorphine on central serotonin neurons. J Pharm Pharmacol (1976) 0.75
[Compounds stimulating central catecholamine receptors]. Postepy Hig Med Dosw (1973) 0.75
Effect of some N,N-disubstituted dithiocarbamates on catecholamines level in rat brain. Biochem Pharmacol (1969) 0.75
Antiarrhythmic efficiency of Craviten and changes in the activities of serum dopamine beta-hydroxylase and erythrocyte membrane ATPases. Cor Vasa (1986) 0.75
The influence of dopaminergic agents on the serotoninergic neurons. Pol J Pharmacol Pharm (1975) 0.75
[Measurements of the width of gingiva, the depth of epithelial attachments and oral vestibule in children and adolescents]. Czas Stomatol (1969) 0.75
[Epidemic of diphtheria in Szczecin-Dabie, in 1963/64]. Przegl Epidemiol (1966) 0.75
[Evaluation of treatment and preventive care for recurrent urolithiasis in children]. Med Wieku Rozwoj (2000) 0.75
[Problem of acromegaly in otolaryngology]. Otolaryngol Pol (1965) 0.75
The action of compound WA-335 on the central nervous system. Arch Immunol Ther Exp (Warsz) (1976) 0.75
Hypotensive action of tyramine in cats. J Pharm Pharmacol (1966) 0.75